Experience
Our management team consists of scientific experts that have 10+ years of experience in the preclinical and clinical aspects of the drug discovery process. Our strengths include Medicinal Chemistry, Cheminformatics, Bioinformatics, ADMET, in vivo Pharmacology in the areas of Metabolic Disease, Oncology and Inflammation. We have expertise in working with various target classes, ranging from Kinases, GPCRs, Proteases and Nuclear Receptors.

Wide range of services
Our in-house experts provide their services as a low cost alternative to manage escalating R&D costs so that you can focus solely on the other important aspects of the drug discovery process. Some of our core services such as in vivo biology (animal and human), in vitro biological assays, structure based drug design, Bioinformatics analyses of new data sets for novel target identification are performed in the United States, based on customer requests for sensitivities around IP liabilities. For closer scrutiny of in vivo studies, we have the option to offer these services in the USA.